July 2022 - The 2023 Peter Joseph Pappas Research Grant application cycle is currently open.
Named for the infant son of preeclampsia survivor Lauren Pappas and her husband Clement, the program seeks to award multiple grants totaling up to $200,000 each year. The ultimate goal of this grant program is to drive research that will eliminate the delivery of pre-term babies as an intervention for severe preeclampsia, HELLP syndrome, and related hypertensive disorders of pregnancy.
Investigators meeting the program’s criteria are invited to submit Letters of Intent for 2022 proposals by August 22, 2022. Letters of Intent that are of interest to the scientific review committee and the Preeclampsia Foundation’s Board of Directors will then be invited to submit full applications by October 8, 2022 with award decisions rendered in December 2022.
Questions? Contact PJPGrants@preeclampsia.org
July 2022 - The 2022 Vision Grant application phase is now closed.
The Preeclampsia Foundation and its affiliate organization Preeclampsia Foundation Canada will each award one medical research Vision Grant to study preeclampsia and related hypertensive disorders of pregnancy, up to $20,000 USD.
Vision Grants are intended to provide initial funding for novel, innovative research by promising young investigators that will advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy. Post-doctoral, Clinical Fellows, or Early Stage Investigators only are eligible to apply. Projects with potential to alter clinical management and improve patient outcomes will receive priority, but any well-considered research proposal will be accepted for review. International applications are welcome; however, submissions must be in English. The Foundation has committed to funding grants that address known research knowledge gaps.
Awardees will be announced in August 2022.
Questions? Contact VisionGrants@preeclampsia.org
Please note: The EMPOWER program is not currently being funded. No applications are being accepted at this time.
EMPOWER (EMpowering Progress in Obstetric and Women's hEalth Research) was established to create partnerships between mentors and single sites or groups within low- and middle-income countries to improve clinical and health services research into the hypertensive disorders of pregnancy.
When available, funding is for a two-year research project. The immediate objective is the completion of a project designed by a local investigator and, when appropriate, the dissemination of the results of the study to change practices and improve care.
EMPOWER is a collaboration of the International Society for the Study of Hypertension in Pregnancy, the Preeclampsia Foundation, PRE-EMPT/Global Pregnancy Collaboration, and supporting organization New Zealand Action on Pre-eclampsia.
Questions? Contact email@example.com
Please contact our Research Manager if you would like the Preeclampsia Foundation to help you recruit participants for a research study or focus group, or have any questions about the Preeclampsia Registry.
The Preeclampsia Foundation published research results.
Answers to our most frequently asked questions about the registry
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
According to the World Health Organization, preeclampsia is one of the least funded areas of research, especially when considered against Disability Adjusted Life Years (DALYs). The Preeclampsia Found...
This grant program drives research to eliminate the delivery of pre-term babies as an intervention for severe preeclampsia, HELLP syndrome, and related hypertensive disorders of pregnancy. Named for t...
Question: Progesterone supplementation - first trimester and beyond - can it help the vascular constriction by keeping the smooth muscle relaxed (17HP shots), and is it associated with early supplemen...
The Preeclampsia Foundation is seeking Letters of Intent for the Peter Joseph Pappas Research Grants funding program, designed to accelerate preeclampsia research. The ultimate goal of this gran...
Promising New Test May Help to Rule-Out Suspected Preeclampsia in At-Risk Pregnant Women To diagnose preeclampsia, healthcare providers rely on measurable signs: a woman’s blood pressure, the...
Planned delivery or expectant management in preeclampsia: an individual participant data meta-analysis Delivery of the baby and the placenta is still the only definitive management for preeclampsia...
Cardiovascular Risk Factors Mediate the Long-Term Maternal Risk Associated With Hypertensive Disorders of Pregnancy Experiencing a hypertensive disorder of pregnancy increases risk for cardiovascul...